EPOPROSTENOL SODIUM - Food and Drug Administration

Set ID
0b0b571c-056a-da12-12a1-e68fb540bb38
Type
Indexing - Product Concept
Effective date
2014-05-08
Version
1
Source
DailyMed source

Mapped DailyMed Labels#

Label, Relation, Manufacturer table
LabelRelationManufacturerEffective
These highlights do not include all the information needed to use EPOPROSTENOL FOR INJECTION safely and effectively. See full prescribing information for EPOPROSTENOL FOR INJECTION. EPOPROSTENOL for injection, for intravenous use Initial U.S. Approval: 1995Product nameGland Pharma Limited2026-01-06
These highlights do not include all the information needed to use EPOPROSTENOL FOR INJECTION safely and effectively. See full prescribing information for EPOPROSTENOL FOR INJECTION. EPOPROSTENOL for injection, for intravenous use Initial U.S. Approval: 1995Product nameSun Pharmaceutical Industries, Inc.2025-04-23
These highlights do not include all the information needed to use FLOLAN safely and effectively. See full prescribing information for FLOLAN. FLOLAN (epoprostenol sodium) for injection, for intravenous use Initial U.S. Approval: 1995Product nameGlaxoSmithKline LLC2023-10-26
These highlights do not include all the information needed to use VELETRI safely and effectively. See full prescribing information for VELETRI. VELETRI ® (epoprostenol) for injection, for intravenous use Initial U.S. Approval: 1995Product nameActelion Pharmaceuticals US, Inc. | Patheon Italia S.p.A. | Cayman Pharma s.r.o. | Wasserburger Arzneimittelwerk GmbH | AndersonBrecon Inc.2022-11-28
These highlights do not include all the information needed to use EPOPROSTENOL FOR INJECTION safely and effectively. See full prescribing information for EPOPROSTENOL FOR INJECTION . EPOPROSTENOL for injection, for intravenous use Initial U.S. Approval: 1995Product nameMylan Institutional LLC2022-05-15